TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
TG Therapeutics(TGTX) stock is priced at $49.87, giving the company a market capitalization of 8.25B. It carries a P/E multiple of 16.81.
As of 2026-08-07, TG Therapeutics(TGTX) stock has fluctuated between $49.11 and $50.19. The current price stands at $49.87, placing the stock +1.5% above today's low and -0.6% off the high.
TG Therapeutics(TGTX) shares are trading with a volume of 709.76K, against a daily average of 2.72M.
In the last year, TG Therapeutics(TGTX) shares hit a 52-week high of $59.30 and a 52-week low of $25.28.
In the last year, TG Therapeutics(TGTX) shares hit a 52-week high of $59.30 and a 52-week low of $25.28.
TGTX News
TG Therapeutics, Inc. reported past second-quarter 2026 results with revenue of US$240.34 million versus US$141.15 million a year earlier, while net income decl...
...
(RTTNews) - TG Therapeutics Inc. (TGTX.OB) reported earnings for second quarter that Dropped, from last year The company's bottom line came in at $7.78 million...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.